Amneal

Bridgewater, United States Founded: 2002 • Age: 24 yrs Listed
Manufacturer of generics formulations

About Amneal

Amneal is a publicly listed company based in Bridgewater (United States) founded in 2002. Manufacturer of generics formulations. The company has 8,300 employees. Amneal has completed 7 acquisitions, including AvKARE, Epsilon Pharmaceuticals and Gemini Laboratories. Its website amneal.com draws about 27 thousand monthly visits. Amneal offers products and services including Generic Products, Specialty Products, and Biosciences Products. Its focus areas include Traditional Pharmaceuticals and Diversified. Its legal entity is Amneal Pharmaceuticals LLC.

Company details

Amneal Pharmaceuticals is a fully-integrated pharmaceutical company focused on the development, manufacture, and distribution of generic and specialty drug products. The company has an extensive portfolio of approximately 250 generic medicines and is expanding its portfolio to include complex dosage forms including biosimilars in a broad range of therapeutic areas. The company also markets a portfolio of branded pharmaceutical products through its specialty segment focused principally on the central nervous system and endocrine disorders.

  • Headquarters Bridgewater, United States
  • Employees 8,300
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website amneal.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Amneal Pharmaceuticals, Inc.
Key Metrics
  • Annual Revenue
    $3.02 B (USD)
    8.05
    as on Dec 31, 2025
  • Net Profit
    $72.06 M (USD)
    as on Dec 31, 2025
  • EBITDA
    $646.66 M (USD)
    9.7
    as on Dec 31, 2025
  • Latest Funding Round
    $19.2M (USD), Post-IPO

    Nov 2018

  • Investors
  • Employee Count
    8,300
  • Investments & Acquisitions
    AvKARE

    & 6 more

Products & Services of Amneal

Amneal offers a comprehensive portfolio of products and services, including Generic Products, Specialty Products, and Biosciences Products.

Generic Products
Pharmaceuticals

Essential generic medicines for treating various common health conditions

Specialty Products
Pharmaceuticals

Innovative drugs for specific diseases like Parkinson's and oncology

Biosciences Products
Pharmaceuticals

Advanced biosimilars for institutional and patient use worldwide

Apps and channels of Amneal

its YouTube channel Amneal Pharmaceuticals has 3.53K subscribers and 30 videos.

Amneal Pharmaceuticals
YouTube 3.53K subscribers 30 videos Autos & Vehicles
Open channel

Videos from Amneal

The most watched videos on Amneal's YouTube channel, Amneal Pharmaceuticals (3.53K subscribers). Click a video to play it here.

Get to Know ONGENTYS® (opicapone) capsules
2.2M views
CREXONT (carbidopa and levodopa) extended-release capsules has transformed innovation into duration
1.8M views
Gasper’s story: Strength, family, and moving forward
287.1K views
Expertise in Complex & Top-Quality Medicines
272.3K views

More on Amneal Pharmaceuticals.

Funding Insights of Amneal

  • Total Rounds 3
  • Last Round Post-IPO — $19.2M
  • Investors Count 3

All 3 funding rounds of Amneal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2018$19.2MPost-IPO––
Feb 2015$250MDebt – Conventional––
Jun 2005Series A––
Valuation history

3 investors in total: 3 institutional.

Investors in Amneal

Amneal has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Northern Trust, GE Capital and Tarsadia.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital and private equity are directed toward multiple sectors.
tarsadia.comNewport Beach, United States
Financial and wealth management services are provided worldwide.
1889northerntrust.comChicago, United States
Commercial aircraft and equipment leasing and lending services are provided.
1932gecapital.comUnited States
Premium access

Investor details for Amneal

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Amneal

137 people are tracked at Amneal (55 in leadership, 9 in board & advisors, 73 in team); the tracked headcount is 8,300.

NameRoleGroup
Sarah Klein
Director, Corporate Counsel - LitigationLeadership
Rose Sobreiro
Director CompensationLeadership
Karan Shroff
Head Of FinanceLeadership
Robert Miranda
Director, Revenue AccountingLeadership
Chintu Patel
Co-CEOLeadership
Divyang Kansara
General Manager Finance & AccountsLeadership
Edwin Medina
Director - Accounts Payable & Travel ServicesLeadership
Gunjan Vanarase
Director Of Compliance (corporate Quality)Leadership
Jane Budson
Senior Director, HR Operations, HRIS & PayrollLeadership
Yiza Soto
Director Of Fp&aLeadership
Rajesh Pandya
Associate Vice PresidentLeadership
Manish Shah
DirectorLeadership
Mathew Joseph
Head HR - Commercial Ops (india And Emerging Markets)Leadership
Sherry Feis
Executive Assistant To Co-ceoLeadership
Timothy Biggiani
Sr. Director, Talent AcquisitionLeadership
Scott Gamache
Director, Technical AccountingLeadership
Tom Gangone
Human Resources DirectorLeadership
Anne Haumacher
Director Learning & DevelopmentLeadership
Ruby Russell
Associate Director, Tax ComplianceLeadership
Tony Dimeo
Vp, Investor RelationsLeadership

117 more people are available in the full profile.

Premium access

Complete people profiles for Amneal

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Amneal

Amneal is a publicly listed company on the NASDAQ with ticker symbol AMRX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date20 Jan 2009
  • Listed onNASDAQ: AMRX
  • Listed entityAmneal Pharmaceuticals, Inc.
  • Exchange sectorHealth technology
  • ISINUS03168L1052
  • Share price$19.57 (-2.3% on the day) · 2026-10-13
  • Market capitalisation$6.25B
  • Price to earnings40.8
  • EPS (diluted, trailing year)$0.48
  • Volume (last session)5,001,278

Financials of Amneal

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$3.02B$72.1M$646.7M
2024$2.79B-$116.9M$589.5M
2023$2.39B-$84.0M$492.4M
2022$2.21B-$130.0M$440.6M
2021$2.09B$10.6M$457.7M
Premium access

Detailed financial statements for Amneal

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Amneal

Amneal has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include AvKARE, Epsilon Pharmaceuticals and Gemini Laboratories.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Biosimilar medicines are developed through integrated biopharmaceutical operations.
kashivbiosciences.comPiscataway, United States2010Apr 2026••••
Therapeutic products are developed and manufactured by Puniska.
puniska.comAhmedabad, India2017Nov 2021$93M
Therapeutic solutions for rare diseases are developed.
kashivsp.comBridgewater, United States2020Jan 2021$70M
Pharmaceuticals and infection control products are distributed by AvKARE.
avkare.comPulaski, United States2007Dec 2019$220M
Drugs are distributed by R&S Northeast in the pharmaceutical sector.
rsnortheast.comPhiladelphia, United States1973Dec 2019$120M
Science-based nutrition products are developed for infants, children, and adults.
geminilabs.comBridgewater, United States2013May 2018••••
Generic oncology pharmaceuticals are manufactured on a contract basis.
epsilonpharma.comHyderabad, India2010Jun 2014$13.5M
Premium access

Complete acquisition details for Amneal

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Amneal

11 dated milestones of Amneal across 24 years, from founding to its latest funding, stage changes and deals.

  1. Founded Amneal is founded.
  2. Funding First funding round.
  3. IPO Lists on the stock exchange (IPO).
  4. Acquisition Acquires Epsilon Pharmaceuticals.
  5. Acquisition Acquires Gemini Laboratories.
  6. Funding Latest funding round, Post-IPO, of $19.2M.
  7. Acquisition Acquires AvKARE.
  8. Acquisition Acquires R&S Northeast.
  9. Acquisition Acquires Kashiv Specialty Pharmaceuticals.
  10. Acquisition Acquires Puniska.
  11. Acquisition Acquires Kashiv BioSciences.

Web traffic of Amneal

The website of Amneal (amneal.com) receives about 26.8K visits a month and ranks #959,075 among all websites worldwide, #1,166 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    26.8K

    ▼ 6.9% vs previous month

  • Unique visitors
    15.1K

    per month

  • Global rank
    #959,075

    among all websites

  • Category rank
    #1,166

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Amneal. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
parpharm.com
100%
View details
geminipharm.com
90%
#2,449,109View details
cebert.com
cebert.com
89%
–
cpc.com
86%
5.7K#3,776,348View details
tevausa.com
86%
63.7K#703,532View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Amneal

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Amneal (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Pharmaceutical products are developed and marketed globally.
2009Montville, New Jersey, United StatesUSD 155.92 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Amneal

Premium access

Complete news archive for Amneal

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amneal

Amneal was founded in 2002 and raised its 1st funding round 3 years after it was founded.

Amneal is headquartered in Bridgewater, United States. It is registered at Bridgewater, New Jersey, United States.

Amneal has 8,300 employees.

Annual revenue of Amneal is $3.02B as on Dec 31, 2025.

Amneal Pharmaceuticals is a fully-integrated pharmaceutical company focused on the development, manufacture, and distribution of generic and specialty drug products. The company has an extensive portfolio of approximately 250 generic medicines and is expanding its portfolio to include complex dosage forms including biosimilars in a broad range of therapeutic areas. The company also markets a portfolio of branded pharmaceutical products through its specialty segment focused principally on the central nervous system and endocrine disorders.

Amneal offers Generic Products, Specialty Products, and Biosciences Products.

Yes, Amneal is publicly traded on NASDAQ under the ticker symbol AMRX.

Amneal has made 7 acquisitions, including AvKARE, Epsilon Pharmaceuticals, and Gemini Laboratories.

Amneal has 3 investors. Key investors include Northern Trust, GE Capital, and Tarsadia.

Amneal operates through Amneal Pharmaceuticals Llc.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available